Cysview

Active Ingredient(s): Hexaminolevulinate Hydrochloride
FDA Approved: * May 28, 2010
Pharm Company: * PHOTOCURE ASA
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cysview Overview

Cysview (hexaminolevulinate HCl) with blue light cystoscopy, is an optical imaging agent designed to enhance detection and visualization of non-muscle invasive bladder cancer (NMIBC), in particular papillary and carcinoma in situ (CIS). It reveals lesions that may not be seen with standard white light cystoscopy. Cysview is marketed in Europe as Hexvix,[1][2] in the United States of America as Cysview, and in Canada as Cysview.[3] Cysview is ma...

Read more Cysview Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cysview

Recent Cysview Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Cysview: (2 results)

Sorted by National Drug Code

• 0407-4086 Cysview Kit by Ge Healthcare Inc.
• 10511-3001 Cysview Kit by Photocure Inc.

Other drugs which contain Hexaminolevulinate Hydrochloride or a similar ingredient: (1 result)

• HEXAMINOLEVULINATE HYDROCHLORIDE